Project Details
Short title | RAvVA:Phase I/II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in Combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy |
---|---|
Status | Finished |
Effective start/end date | 10/07/12 → 31/12/22 |
Funding
- CELGENE INTERNATIONAL SARL